5.3 Metabolic improvements GLP-1 receptor agonists have diverse benefits beyond weight reduction, enhancing many metabolic parameters
Visit the GLPro GLPatch Official Page Quick Answer: Is GLPro GLPatch a GLP-1 Drug
This study further demonstrated that exendin-4 treatment additionally reduced the presence of key inflammatory molecules, including TNF-alpha, interleukin 1 beta (IL-1beta), and IL-6, in mice livers [46], providing evidence for potential GLP-1 treatment for inflammation related to steatohepatitis
Pasireotide , a somatostatin analogue that is longer-acting than octreotide, is approved for use in Cushing disease and acromegaly and actually causes hyperglycemia
It's important to choose patches with complementary benefits and avoid pairing patches with opposing effects
Figure 2: Diseases associated with obesity and global numbers (Source: Novo) Thankfully, these can (to some extent) be addressed through losing weight